Please login to the form below

Not currently logged in
Email:
Password:

Ziarco

This page shows the latest Ziarco news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago.

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Ziarco appoints Mike Grey to board of directors Ziarco appoints Mike Grey to board of directors

    Ziarco appoints Mike Grey to board of directors. He is chairman and CEO of Reneo Pharmaceuticals. ... Ed Mathers, chairman of Ziarco, commented: “ We are thrilled to welcome Mike to Ziarco's board of directors.

  • Former Pfizer R&D head LaMattina to advise Ziarco Former Pfizer R&D head LaMattina to advise Ziarco

    Former Pfizer R&D head LaMattina to advise Ziarco. He previously spent 30 years at US pharma firm. ... UK-based biotech Ziarco has hired former head of R&D at Pfizer, Dr John LaMattina, as a strategic R&D adviser.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics